Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OSR HealthOSRH -5.47%8 Receivables Turnover is 1.67 as of Mar. 2026. GuruFocus rates OSRH with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 841 Biotechnology companies, OSR Health ranks worse than 52.44% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. OSR Health's Revenue for the
three
months ended in Mar. 2026 was $0.48 Mil. OSR Health's average Accounts Receivable for the
three
months ended in Mar. 2026 was $0.29 Mil.
Hence, OSR Health's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.67.
OSR Health (NAS:OSRH) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
OSR Health Receivables Turnover Related Terms
OSR Health Receivables Turnover Historical Data
* Premium members only.
The historical data trend for OSR Health's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSRH vs TOVX, PBM, PHIO: Receivables Turnover Comparison
For the Biotechnology subindustry, OSR Health's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OSR Health Receivables Turnover vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, OSR Health's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where OSR Health's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSR Health (OSRH) has a Receivables Turnover of 1.67 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on OSR Health and its competitors. According to the industry distribution chart, OSR Health ranks #441 out of 841 companies in the Biotechnology industry, placing it in the top 52.4%.
Is OSR Health's Receivables Turnover too high?
OSR Health's current Receivables Turnover is 1.67. The Biotechnology industry median Receivables Turnover is 5.29. OSR Health's value of 1.67 is 68.4% below this industry median. Based on the distribution chart, OSR Health ranks #441 out of 841 companies in the Biotechnology industry, which is below the industry midpoint. Overall, OSR Health has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does OSR Health's Receivables Turnover compare to TOVX and PBM?
According to the Biotechnology industry distribution chart, OSR Health ranks #441 out of 841 companies for Receivables Turnover. This places OSR Health in the lower half of its industry. The industry median Receivables Turnover is 5.29. OSR Health's value of 1.67 is 68.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Biotechnology company?
The median Receivables Turnover among Biotechnology companies is 5.29, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OSR Health's current Receivables Turnover of 1.67 is 68.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on OSR Health and its competitors. For the Biotechnology industry, the median Receivables Turnover is 5.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OSR Health's current Receivables Turnover is 1.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OSR Health stock overvalued right now?
OSR Health (OSRH) has a current Receivables Turnover of 1.67. The current Receivables Turnover is 1.67 and 68.4% below the Biotechnology industry median of 5.29. OSR Health's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For OSR Health (OSRH), the current Receivables Turnover is 1.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
OSR Health Inc is a healthcare group that operates through a portfolio of subsidiary companies. It focuses on developing and supporting healthcare businesses and initiatives across the healthcare sector.
8GF Score
Get the complete analysis for OSRH
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSRH has been successfully added to your 
